Find an expert

Dr. Thao Ninh obtained her PhD degree from School of Agriculture and Food Sustainability, The University of Queensland in 2021. Her research during her doctoral studies aimed to uncover the function of the Heterotrimeric G proteins in plants. By using gene editing technology CRISPR/Cas9 to knockout G alpha and G beta gene in tomato, Dr. Thao found that the phenotypes of tomato G alpha/beta-knockout mutants are very similar to those observed in monocots, but not in Arabidopsis. Her research results, therefore, raise important questions about whether some G protein functions/signaling have been lost in Arabidopsis during evolution. In 2023, Dr. Thao joined the Mitter group as postdoctoral researcher. Her current research focuses on using CRISPR/Ca9 technology in crop improvement including modulation in fruit appearance in strawberry, disease resistance in tomato, plant architecture in avocado and other preferred traits of various crops.

Dr. Mehwish Nisar is a trained medical doctor, researcher, and academic with a rich background in both clinical practice and higher education. With over a decade of teaching experience in tertiary institutions and medical schools across Australia and internationally, she brings extensive expertise in healthcare education and research.

Specialising in mixed-methods co-design studies, Dr. Nisar's research focuses on chronic diseases, especially diabetes and health behaviours with a strong emphasis on implementation science. She currently serves as a Postdoctoral Research Fellow at the UQ School of Health and Rehabilitation Sciences, leading a project dedicated to improving health outcomes for Culturally and Linguistically Diverse (CALD) communities. Dr. Nisar earned her Ph.D. in Public Health from the University of Queensland, where her research explored chronic diseases and lifestyle risk factors among immigrant populations. Based on her expertise in migrant health advocate, she is featured in the United Nations Migration Health and Development Research Initiative (MHADRI) portal, recognising her contributions to advancing knowledge in this critical area.

Her skill set includes effectively communicating complex health information, conducting data analysis, designing research projects, and developing public health awareness materials. She is also proficient in various research software and has played a key role in course design and student mentorship. An active member of multiple professional associations and community organizations, Dr. Nisar is committed to fostering meaningful collaborations with communities and stakeholders. Her mission is to bridge healthcare gaps and promote global health equity through evidence-based research and innovative public health initiatives.

.

Professor Nissen is Director, and Taylor Family Chair, of the Centre for the Business and Economics of Health (CBEH), Faculty of Business Economics and Law at The University of Queensland. She has been a prominent health practitioner leader, educator, researcher, and implementation scientist nationally and internationally for more than 25 years. A pharmacist by training, her research has driven major health system change, notably leading to the introduction of immunization services by pharmacists throughout Australia (Queensland Pharmacists Immunization Pilot (QPIP), (2014-15) and more recently the Urinary Tract Infection Pharmacy Pilot – Queensland (UTIPP-Q, 2020-21), both Australian firsts. Before joining UQ, Lisa was previously Head of the School of Clinical Sciences at QUT (2012-22) overseeing the training for 2,500 students per year across seven clinical disciplines. In late 2022 she returned to UQ, taking on a new and innovative role as Director of the EvolveHealth Health Workforce Optimisation Program at CBEH. This program is part of the seven strategic Health Research Accelerator (HERA) initiatives announced by UQ in 2022, which will address some of the most pressing health and medical challenges of today.

Lisa has had career-long leadership and executive roles with national boards and state committees including the Pharmaceutical Society of Australia, the Society of Hospital Pharmacists of Australia, Family Planning Queensland, and Hepatitis Queensland. Professor Nissen was a ministerial appointment to the Queensland Health Interim Pharmacy Round Table overseeing the implementation of a council to govern pharmacy ownership in Queensland. She is also a ministerial appointment to the Queensland Health Voluntary Assisted Dying Review Board. She is on governance boards various other health organization groups including the Optometry Council of Australia and New Zealand Board, and the AHPRA scheduled medicines expert committee.

Professor Nissen focuses on strategic collaborations across the healthcare continuum with key partnerships in government, professional boards, associations, university, and other industry and consumer groups. These have led to the implementation of multiple complex practice change interventions. She has a proven record of bringing together these groups to focus on establishing multidisciplinary care teams to provide consumer-centric health care. This often means challenging currently held views of the scope of practice of health professionals, drawing on her high-level collaboration and negotiation skills.

Professor Nissen has supervised more than 80 higher degree research students and published over 180 peer-reviewed journal articles, and 200 professional publications. She has given more than 250 invited keynotes, plenary, and workshop presentations. In the past 5 years she has generated more than $9M in competitive research funding.

Michael has over 30 years’ experience in clinical medicine (infectious diseases & paediatrics) and clinical laboratory microbiology with a particular interest in the epidemiology of vaccine preventable diseases and the diagnosis of infectious diseases in hospital, public health and industry settings. He recently took up the inaugural Director of Research at The Prince Charles Hospital in Brisbane.

He is a past Principal Medical Officer and Director of CoVID-19 Pharmacovigilance at the Therapeutic Goods Administration, Department of Health & Ageing, Australian Government (2021-2022), Director of Scientific Affairs & Public Health for GSK Vaccines in the Greater China Intercontinental region based in Singapore (2014-2020) and Director of Infectious Diseases at the Royal Children’s Hospital-Brisbane and a practising Clinical Microbiologist at the Royal Brisbane & Women’s Hospitals (2000-2014). Michael is a past full member of the Australian Technical Advisory Group for Immunisation from 2007 to 2013.

Prof. Nissen has 223 peer-reviewed medical publications and book chapters, a h- index of 64 with 13,321 citations of his work to date. His research interests include the epidemiology and prevention of vaccine preventable diseases and the rapid molecular diagnostic techniques of infectious diseases.

Dr Marloes Dekker Nitert is an Associate Professor at The University of Queensland. Marloes is a biomedical researcher with a PhD from Lund University in Sweden. Her research focuses on the role of metabolism in complications of pregnancy. She currently heads a laboratory research group at the School of Chemistry and Molecular Biosciences studying the role of metabolism in pregnancy complications and especially how the gut microbiome contributes to a healthy pregnancy and to pregnancy complications. Marloes works closely together with clinician-scientists and clinicians at the Royal Brisbane and Women’s Hospital and the Mater Mothers' Hospital to do her translational research. Marloes is a board member of the Australian Society for Medical Research and a past Council member of the Society of Obstetric Medicine Australia and New Zealand.

Michael Noad graduated with a Bachelor of Veterinary Science from UQ in 1990. After working primarily as a small animal vet in Queensland and the UK, Mike returned to Australia to undertake a PhD in humpback whale acoustic behaviour at the University of Sydney in 1995. In 2002, after finishing his PhD, Mike became a postdoctoral fellow in the School of Integraitve Biology at UQ. In 2003 he was employed as a lecturer in the School of Veterinary Science. He is currently a professor at UQ, dividing his time between veterinary science, where he teaches anatomy, and marine science, the focus of his research. In 2019 he became the Academic Director of the Moreton Bay Research Station, and in 2022 the Director of the Centre for Marine Science while still retaining a substantive apointment in the School of Veterinary Science.

Research:

The key areas of Mike's research are the effects of anthopogenic underwater noise on whales, the evolution and function of humpback whale song, social learning and culture in animals, and marine mammal population ecology. With regards to the effects of anthropogenic underwater noise on whales, there is currently a great deal of concern about how anthropogenic noise such as military sonar, oil and gas exploration activity and commercial shipping traffic, may adversely affect marine mammals. Mike has been involved in several large collaborative projects in this area, the largest being BRAHSS where the team studied the behavioural changes of humpback whales in response to powerful seismic airguns. His work on the evolution and function of humpback whale song is focused on how the animals themselves use sound to communicate. The songs of these whales is one of the most complex acoustic displays of any animal known. The songs are not static, but constantly change, and although the songs are almost certainly used as a sexual signal, the changing nature of the song makes understanding how this works challenging. His work on social learning and culture in animals also involves humpback whale songs, but focuses on how the whales learn the songs from each other, both within and between populations. As the patterns are usually unique to a population but can be transmitted over time to other populations, humpback song is the most extreme example of a vocal cultural trait in any species as well as an excellent model for studying social learning, the process whereby the whales perceive and learn new songs. Mike's last research area is marine mammal population ecology, and the primary project is the population ecology of the east Australian humpback whales. This population was almost completely extirpated in the early 1960s through hunting, but has since undergone a rapid recovery. Its long term trajectory, however, is uncertain due to a number of factors including possibly overshooting the natural carrying capacity of the population, and climate change.

Christy is registered pharmacist with more than 17 years’ experience as a clinical educator and educational researcher, in both academic and clinical settings. Her clinical education experiences have been underpinned by my formal postgraduate qualifications, Master of Education (Clinical Education) and Doctor of Philosophy (Pharmacy Education). Her Doctor of Philosophy (University of Queensland, 2014) examined pharmacy curriculum and its influence on professional identity formation. This research has served as a platform for an ongoing research program in workplace learning in medical and health professional education, which has been recognised internationally.

I’m an Associate Professor of Psychology driven by the goal of safeguarding humanity’s future through effective AI governance. My career began with a strong focus on evidence synthesis, meta-analysis, and knowledge translation in health, education, and leadership settings. This background honed my ability to tackle large, complex problems by integrating insights from multiple research disciplines, and by designing interventions that reach people at scale.

I now channel these skills into understanding and mitigating the risks posed by advanced artificial intelligence. Drawing on my experience leading large, multi-stakeholder projects, I use rigorous methods—from systematic reviews to agile-based project management—to generate robust, transparent evidence for policymakers and practitioners. Through roles such as Director at Effective Altruism Australia, I also contribute to shaping philanthropic and public policy strategies around AI risk.

Ultimately, my work aims to merge best-practice research with real-world solutions, ensuring that advanced AI is developed and governed responsibly for the long-term benefit of society.

Prof Kazuhiro Nogita’s research interests are in: working on Pb-free solder alloys and intermetallics, hydrogen storage alloys, Li-ion battery anode materials, Zn-Al coating alloys and structural Al-Si and Mg alloys. The unifying theme throughout his research career has been the development of environmentally sustainable materials solutions for conventional and alternative electronic, transport and power industries.

Prof Nogita graduated as an Engineer in Japan in 1990 and worked in the nuclear power industry with Hitachi Ltd. for several years. He was awarded a PhD from Kyushu University in 1997 and has subsequently worked on a variety of research projects, including the development of materials for alternative power industries and environmentally friendly applications. He migrated to Australia in 1999 after accepting a position at the University of Queensland, where he currently holds the title of Professor and Director of the Nihon Superior Centre for the Manufacture of Electronic Materials (NS CMEM) within the School of Mechanical & Mining Engineering, and a founding manager of The University of Queensland - Kyushu University Oceania Project (“UQ-KU Project”). He is also an invited Professor at Kyushu University and at the University of Malaysia Perlis.

Currently, the majority of Prof Nogita’s research is in two major areas, namely lead-free solders for electronic applications and metal based hydrogen-storage alloys. He holds 15 international patents and has authored over 200 refereed scientific papers. His research has been acknowledged with several awards/fellowships, including Queensland Government Smart Futures Fellowship and he has been instrumental in the establishment of a spin-off company, Hydrexia Pty. Ltd.

Maggie Nolan is an Associate Professor in Digital Cultural Heritage in the School of Communication and Arts and the recently appointed Director of AustLit. AustLit is a comprehensive information resource and research environment for Australian literary, print, and narrative culture and it supports and promotes research into Australian story-telling.

Maggie values interdisciplinary and collaborative approaches to humanities research.

Maggie's research is in the broad field of Australian Literary Cultures. Her most recent project, "Close Relations: Irishness in Australian Literature", with Professor Ronan McDonald (UoM) and Professor Kath Bode (ANU) was awarded an ARC Discovery Grant in 2022.

Her research interests include:

• Contemporary Indigenous Literatures
• Hoaxes, Imposture and Mistaken Identity in Australian Literary Culture
• Reading, reception and the civic role of book clubs
• Digital literary studies
• Value in literary studies and the impact of ranking systems on the discipline.

Maggie is an experienced postgraduate supervisor and is available to supervise topics on Australian literary cultures. She also welcomes students and researcher who would like to work on projects linked to AustLit.

Dr Nones research program is focused in using genomics to better understand the molecular aspects of cancer development and response to treatment. Her work encompassed a series of cancer types including oesophageal, pancreatic, breast and lung cancers. Cancer genomics is impacting patient care through precision medicine. Her work is contributing to two areas: i) our understanding of tumour development and progression by identifying new genes and/or mechanisms that drive cancer progression or response to treatment; and ii) investigating steps to improve the translation of genomics into patient care to improve outcomes for cancer patients.